OBiO Technology (Shanghai) Corp., Ltd (688238.SH) is a China-based biotechnology company and CRO/CDMO group focusing on cell and gene therapy. The company provides end-to-end offerings including process development, analytical method development, IND-enabling CMC, and clinical and commercial contract manufacturing of viral vectors, oncolytic viruses, and cell therapy products. OBiO operates a 10,000-square-meter GMP campus (Intelli-M PINE Site) with 29 GMP production lines.
viral vector manufacturing (AAV, lentivirus), cell therapy CDMO, gene therapy CDMO, GMP plasmid DNA production, oncolytic virus manufacturing
1 site worldwide
No reviews available yet.
No documents available.